March of Dimes Innovation Fund

The March of Dimes Innovation Fund is a charitable foundation established by the March of Dimes, a nonprofit organization dedicated to improving the health of mothers and babies in the United States. The fund focuses on investing in early-stage companies that address critical challenges in maternal and infant health, aiming to accelerate the development and implementation of innovative solutions to enhance health outcomes for families nationwide. By leveraging philanthropic contributions, the fund supports ventures that align with the March of Dimes' mission to combat maternal and infant health crises, including high rates of maternal mortality and preterm birth in the U.S.

The fund's investment strategy targets companies developing technologies and services that prevent adverse pregnancy outcomes, support maternal mental health, and improve access to quality care. Investments are guided by an Investment Committee comprising experts in venture capital and maternal health, ensuring that each decision is informed by clinical expertise and designed to build a high-impact venture portfolio. The fund collaborates with other impact-driven venture funds and partners with nonprofit and government organizations to strengthen the ecosystem of maternal and infant health innovation.

Since its inception, the March of Dimes Innovation Fund has invested in several pioneering companies, including Raydiant Oximetry, PyrAmes, Seven Starling, Novocuff, Millie, and Iron Health. These portfolio companies are developing solutions ranging from fetal oxygenation monitoring and continuous blood pressure monitoring to virtual therapy for perinatal mood disorders and innovative maternity care models. The fund continues to seek and support early-stage companies with promising solutions to improve maternal and infant health outcomes across the United States.